These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 12018020

  • 1. Assessment of cancer risk and environmental levels of arsenic in New Hampshire.
    Karagas MR, Stukel TA, Tosteson TD.
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):85-94. PubMed ID: 12018020
    [Abstract] [Full Text] [Related]

  • 2. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population.
    Karagas MR, Tosteson TD, Blum J, Morris JS, Baron JA, Klaue B.
    Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1047-50. PubMed ID: 9703491
    [Abstract] [Full Text] [Related]

  • 3. Intra-individual variability in toenail arsenic concentrations in a Michigan population, USA.
    Slotnick MJ, Meliker JR, Nriagu JO.
    J Expo Sci Environ Epidemiol; 2008 Mar; 18(2):149-57. PubMed ID: 17426735
    [Abstract] [Full Text] [Related]

  • 4. Markers of low level arsenic exposure for evaluating human cancer risks in a US population.
    Karagas MR, Le CX, Morris S, Blum J, Lu X, Spate V, Carey M, Stannard V, Klaue B, Tosteson TD.
    Int J Occup Med Environ Health; 2001 Mar; 14(2):171-5. PubMed ID: 11548067
    [Abstract] [Full Text] [Related]

  • 5. Sampling private wells at past homes to estimate arsenic exposure: a methodologic study in New England.
    Colt JS, Baris D, Clark SF, Ayotte JD, Ward M, Nuckols JR, Cantor KP, Silverman DT, Karagas M.
    J Expo Anal Environ Epidemiol; 2002 Sep; 12(5):329-34. PubMed ID: 12198581
    [Abstract] [Full Text] [Related]

  • 6. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
    Michaud DS, Wright ME, Cantor KP, Taylor PR, Virtamo J, Albanes D.
    Am J Epidemiol; 2004 Nov 01; 160(9):853-9. PubMed ID: 15496537
    [Abstract] [Full Text] [Related]

  • 7. Identifying US populations for the study of health effects related to drinking water arsenic.
    Frost FJ, Muller T, Petersen HV, Thomson B, Tollestrup K.
    J Expo Anal Environ Epidemiol; 2003 May 01; 13(3):231-9. PubMed ID: 12743617
    [Abstract] [Full Text] [Related]

  • 8. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.
    Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, Schned A.
    Cancer Causes Control; 2004 Jun 01; 15(5):465-72. PubMed ID: 15286466
    [Abstract] [Full Text] [Related]

  • 9. Arsenic exposure in US public and domestic drinking water supplies: a comparative risk assessment.
    Kumar A, Adak P, Gurian PL, Lockwood JR.
    J Expo Sci Environ Epidemiol; 2010 May 01; 20(3):245-54. PubMed ID: 19401722
    [Abstract] [Full Text] [Related]

  • 10. Estimating water supply arsenic levels in the New England Bladder Cancer Study.
    Nuckols JR, Freeman LE, Lubin JH, Airola MS, Baris D, Ayotte JD, Taylor A, Paulu C, Karagas MR, Colt J, Ward MH, Huang AT, Bress W, Cherala S, Silverman DT, Cantor KP.
    Environ Health Perspect; 2011 Sep 01; 119(9):1279-85. PubMed ID: 21421449
    [Abstract] [Full Text] [Related]

  • 11. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
    Lamm SH, Robbins SA, Zhou C, Lu J, Chen R, Feinleib M.
    Regul Toxicol Pharmacol; 2013 Feb 01; 65(1):147-56. PubMed ID: 23137931
    [Abstract] [Full Text] [Related]

  • 12. Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
    Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, Nelson HH, Kelsey KT.
    Carcinogenesis; 2006 Jan 01; 27(1):112-6. PubMed ID: 15987713
    [Abstract] [Full Text] [Related]

  • 13. Arsenic level in drinking water and mortality of lung cancer (Taiwan).
    Guo HR.
    Cancer Causes Control; 2004 Mar 01; 15(2):171-7. PubMed ID: 15017129
    [Abstract] [Full Text] [Related]

  • 14. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study.
    Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, Greenberg ER.
    Am J Epidemiol; 2001 Mar 15; 153(6):559-65. PubMed ID: 11257063
    [Abstract] [Full Text] [Related]

  • 15. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
    Tsuji JS, Alexander DD, Perez V, Mink PJ.
    Toxicology; 2014 Mar 20; 317():17-30. PubMed ID: 24462659
    [Abstract] [Full Text] [Related]

  • 16. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water.
    Andrew AS, Karagas MR, Hamilton JW.
    Int J Cancer; 2003 Apr 10; 104(3):263-8. PubMed ID: 12569548
    [Abstract] [Full Text] [Related]

  • 17. Association of arsenic-contaminated drinking-water with prevalence of skin cancer in Wisconsin's Fox River Valley.
    Knobeloch LM, Zierold KM, Anderson HA.
    J Health Popul Nutr; 2006 Jun 10; 24(2):206-13. PubMed ID: 17195561
    [Abstract] [Full Text] [Related]

  • 18. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan.
    Chen CL, Chiou HY, Hsu LI, Hsueh YM, Wu MM, Wang YH, Chen CJ.
    Cancer Epidemiol Biomarkers Prev; 2010 Jan 10; 19(1):101-10. PubMed ID: 20056628
    [Abstract] [Full Text] [Related]

  • 19. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.
    Mink PJ, Alexander DD, Barraj LM, Kelsh MA, Tsuji JS.
    Regul Toxicol Pharmacol; 2008 Dec 10; 52(3):299-310. PubMed ID: 18783726
    [Abstract] [Full Text] [Related]

  • 20. Toenail samples as an indicator of drinking water arsenic exposure.
    Karagas MR, Morris JS, Weiss JE, Spate V, Baskett C, Greenberg ER.
    Cancer Epidemiol Biomarkers Prev; 1996 Oct 10; 5(10):849-52. PubMed ID: 8896897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.